Inclusion Criteria:~* Subject who meets the National Institute on Aging and the Alzheimer's Association
(NIA-AA) clinical criteria for mild cognitive impairment or probable AD, and have:~ * Clinical Dementia Rating
(CDR)-Global Score of 0.5~ * Mini-Mental State Examination (MMSE) score of 22 to 30, inclusive~ * Repeatable
Battery for the Assessment of Neuropsychological Status-Delayed Memory Index (RBANS - DMI) score of 85 or
lower~* Subject has a positive amyloid positron emission tomography (PET) scan.~* Subject has a Modified
Hachinski Ischemic Scale (MHIS) score of â‰¤ 4.~* The subject has an identified, reliable, study partner (e.g.,
family member).~* If using medications to treat symptoms related to AD, doses must be stable for at least 12
weeks prior to randomization.~
